DIVIGEL DIN 02424924
Health Canada record
| Active ingredient(s) | ESTRADIOL 0.1 % |
|---|---|
| Dosage form | Gel |
| Route | Transdermal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03CA03 ESTRADIOL |
| Original market date | 13-Apr-2015 |
| Current status date | 29-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Searchlight Pharma Inc — licence 102247, currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ESTRADIOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02249405 | ACTIVELLE | NOVO NORDISK CANADA INC | Tablet | ESTRADIOL 1 MG; NORETHINDRONE ACETATE 0.5 MG | Marketed |
| 02309009 | ACTIVELLE LD | NOVO NORDISK CANADA INC | Tablet | ESTRADIOL 0.5 MG; NORETHINDRONE ACETATE 0.1 MG | Marketed |
| 02449803 | COMPONENT TE-G IMPLANTS WITH TYLAN | ELANCO CANADA LIMITED | Implant | ESTRADIOL 8 MG; TRENBOLONE ACETATE 40 MG; TYLOSIN TARTRATE 29 MG | Marketed |
| 00590932 | COMPUDOSE | ELANCO CANADA LIMITED | Implant | ESTRADIOL 25.7 MG | Marketed |
| 02424835 | DIVIGEL | SEARCHLIGHT PHARMA INC | Gel | ESTRADIOL 0.1 % | Marketed |
| 02424843 | DIVIGEL | SEARCHLIGHT PHARMA INC | Gel | ESTRADIOL 0.1 % | Marketed |
| 02241835 | ESTALIS 140/50 MCG | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 50 MCG; NORETHINDRONE ACETATE 140 MCG | Marketed |
| 02241837 | ESTALIS 250/50 MCG | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 50 MCG; NORETHINDRONE ACETATE 250 MCG | Marketed |
| 02451239 | ESTRADIOL | PHARMASCIENCE INC | Tablet | ESTRADIOL 0.5 MG | Approved |
| 02451255 | ESTRADIOL | PHARMASCIENCE INC | Tablet | ESTRADIOL 2 MG | Approved |
| 02451247 | ESTRADIOL | PHARMASCIENCE INC | Tablet | ESTRADIOL 1 MG | Approved |
| 02244002 | ESTRADOT 100 | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 100 MCG | Marketed |
| 02245676 | ESTRADOT 25 | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 25 MCG | Marketed |
| 02243999 | ESTRADOT 37.5 | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 37.5 MCG | Marketed |
| 02244000 | ESTRADOT 50 | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 50 MCG | Marketed |
| 02244001 | ESTRADOT 75 | SANDOZ CANADA INCORPORATED | Patch | ESTRADIOL 75 MCG | Marketed |
| 02168898 | ESTRING | PFIZER CANADA ULC | Ring (Slow-Release) | ESTRADIOL 2 MG | Marketed |
| 02250616 | CLIMARA PRO | BAYER INC | Patch | ESTRADIOL 45 MCG; LEVONORGESTREL 15 MCG | Cancelled Post Market |
| 02377098 | DIVIGEL | TEVA CANADA LIMITED | Gel | ESTRADIOL 0.1 % | Cancelled Post Market |
| 02243530 | ESTALIS SEQUI | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 0.51 MG; NORETHINDRONE ACETATE 4.8 MG; ESTRADIOL 4.33 MG | Cancelled Post Market |
| 02243529 | ESTALIS SEQUI | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 0.62 MG; NORETHINDRONE ACETATE 2.7 MG; ESTRADIOL 4.33 MG | Cancelled Post Market |
| 00464791 | ESTRACE TAB 1MG | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Tablet | ESTRADIOL 1 MG | Cancelled Post Market |
| 00464805 | ESTRACE TAB 2MG | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Tablet | ESTRADIOL 2 MG | Cancelled Post Market |
| 02108186 | ESTRACOMB | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 4 MG; NORETHINDRONE ACETATE 30 MG; ESTRADIOL 10 MG | Cancelled Post Market |
| 00756792 | ESTRADERM-100 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | ESTRADIOL 8 MG | Cancelled Post Market |
| 00756849 | ESTRADERM-25 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | ESTRADIOL 2 MG | Cancelled Post Market |
| 00756857 | ESTRADERM-50 | NOVARTIS PHARMACEUTICALS CANADA INC | Patch (Extended-Release) | ESTRADIOL 4 MG | Cancelled Post Market |
| 02243726 | OESCLIM | SEARCHLIGHT PHARMA INC | Patch | ESTRADIOL 100 MCG | Cancelled Post Market |
| 02243725 | OESCLIM | SEARCHLIGHT PHARMA INC | Patch | ESTRADIOL 75 MCG | Cancelled Post Market |
| 02243724 | OESCLIM | SEARCHLIGHT PHARMA INC | Patch | ESTRADIOL 50 MCG | Cancelled Post Market |
| 02243723 | OESCLIM | SEARCHLIGHT PHARMA INC | Patch | ESTRADIOL 37.5 MCG | Cancelled Post Market |
| 02243722 | OESCLIM | SEARCHLIGHT PHARMA INC | Patch | ESTRADIOL 25 MCG | Cancelled Post Market |
| 02237808 | OESCLIM | FOURNIER PHARMA INC | Patch | ESTRADIOL 10 MG | Cancelled Post Market |
| 02237807 | OESCLIM | FOURNIER PHARMA INC | Patch | ESTRADIOL 5 MG | Cancelled Post Market |
| 02148587 | PMS-ESTRADIOL | PHARMASCIENCE INC | Tablet | ESTRADIOL 1 MG | Dormant |
| 02225190 | PMS-ESTRADIOL | PHARMASCIENCE INC | Tablet | ESTRADIOL 0.5 MG | Dormant |
| 02148595 | PMS-ESTRADIOL | PHARMASCIENCE INC | Tablet | ESTRADIOL 2 MG | Dormant |
| 02247906 | PREFESTA | SEARCHLIGHT PHARMA INC | Tablet | ESTRADIOL 1 MG; ESTRADIOL 1 MG; NORGESTIMATE 90 MCG | Cancelled Pre Market |
| 02241332 | VAGIFEM | NOVO NORDISK CANADA INC | Vaginal Tablet | ESTRADIOL 25 MCG | Cancelled Post Market |
| 02204444 | VIVELLE 100MCG | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 8.66 MG | Cancelled Post Market |
| 02204401 | VIVELLE 37.5MCG | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 3.28 MG | Cancelled Post Market |
| 02204428 | VIVELLE 50MCG | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 4.33 MG | Cancelled Post Market |
| 02204436 | VIVELLE 75MCG | NOVARTIS PHARMACEUTICALS CANADA INC | Patch | ESTRADIOL 6.56 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21593 | 2018-11-29 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
International API supply for ESTRADIOL
0 valid EDQM Certificates of Suitability from 0 holders. 28 active FDA Drug Master Files.
Request a quote for DIVIGEL